Leonteq Securities AG’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-820
Closed -$61.4K 1251
2023
Q3
$61.4K Buy
+820
New +$72.7K ﹤0.01% 761
2023
Q2
Sell
-300
Closed -$31.1K 1277
2023
Q1
$31.1K Hold
300
﹤0.01% 883
2022
Q4
$34.6K Hold
300
﹤0.01% 889
2022
Q3
$32.5K Hold
300
﹤0.01% 884
2022
Q2
$54.2K Buy
+300
New +$53.7K ﹤0.01% 807
2021
Q4
Sell
-180
Closed -$34.7K 1306
2021
Q3
$34.7K Buy
+180
New +$44.3K ﹤0.01% 895

Other funds holding MED

Leonteq Securities AG's MED Position: Q4 2023 in Review

Leonteq Securities AG sold out of Medifast (MED) in Q4 2023, closing a stake of 820 shares — an estimated $61.4K sold.

Leonteq Securities AG first reported a position in MED in Q3 2021 and held it in 6 quarters. The position peaked at $61.4K in Q3 2023. 216 funds tracked by Wall St. Rank hold MED as of Q4 2023.

  • Leonteq Securities AG reported no remaining Medifast position as of Q4 2023 after selling out during the quarter.
  • Leonteq Securities AG sold 820 Medifast shares in Q4 2023, an estimated $61.4K.
  • Leonteq Securities AG first reported a position in Medifast in Q3 2021 and held it in 6 quarters.
  • Leonteq Securities AG's Medifast position peaked at $61.4K in Q3 2023.
  • 216 funds tracked by Wall St. Rank held Medifast as of Q4 2023.

Based on Leonteq Securities AG's 13F filing for Q4 2023, filed 11 Mar 2026.